Overview

The Therapeutic Goods (Charges) Amendment (2026 Measures No. 1) Regulations 2026 is a federal regulation that amends the fees and charges framework under the Therapeutic Goods (Charges) Act 1989. It is administered by the Department of Health, Disability and Ageing.

Key dates

What the regulation covers

The regulation amends the charges framework applying to therapeutic goods. The source legislation and explanatory statement do not detail which specific charges were amended, by how much, or which types of therapeutic goods registrations or licences are affected.

Key actions

This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.